Advertisement
Articles
Advertisement

GlaxoSmithKline's CFO on Q3 and Emerging Markets Business

Wed, 10/23/2013 - 12:15pm

GlaxoSmithKline's CFO, Simon Dingemans, discusses sales growth and strong cash generation in the third quarter, research and development activity, as well as emerging markets and China.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading